Healthcare
TPG and Carlyle circle MCAG's Regis
TPG Capital Partners and The Carlyle Group are said to be interested in buying Australia’s second-largest private care home operator, Regis Group.
Connaughton: Foreign GPs must differentiate to compete with locals in Asia
Foreign GPs seeking investment opportunities in Asia need to differentiate themselves in order to compete with local funds, according to John Connaughton, managing director of Bain Capital.
Australian PE investment at 'highest level for three years'
Private equity and venture capital firms contributed A$3.6 billion ($3.7 billion) of capital to Australian companies this year, representing the highest amount invested for three years.
Northern Light eyes healthcare sector
Healthcare will be a stronger area of focus for Northern Light Venture Capital’s third US-dollar fund, which last week achieved a final close of $400 million.
NVP India broadens focus to include into seed, late-stage deals
Norwest Venture Partners (NVP) India is expanding its investment strategy to include seed and late-stage transactions, having previously focused on venture and growth deals. The firm is also broadening its sector coverage to include healthcare, education...
Tokio Marine targets $903m Showa Yakuhin Kako sale - report
Tokio Marine capital has launched the sales process for its 50% stake in Japanese drug producer Showa Yakuhin Kako, targeting up to JPY70 billion ($905 million), according to Reuters.
Olympus, India Value Fund back DM Healthcare
Olympus Capital Holdings is considering purchasing a minority stake in Indian hospital owner DM Healthcare for INR600 billion ($125 million).
VC-backed Newsummit in $100m JV with US biomed fund
Sequoia-backed Newsummit Pharmaceutical Group, a biomed developer based in Shanghai, has partnered with Cleveland Bio Fund (CBF) to launch a $100 million vehicle to invest in American medical device companies.
Indian drug maker Vivimed gets $25.8m from private equity
NYLIM Jacob Ballas India Fund and Kitara Capital have committed INR1.27 billion ($25.8 million) to Indian pharmaceutical firm Vivimed Labs.
Malaysia's Khazanah in running for Turkish hospital owner
Malaysian sovereign wealth fund Khazanah Nasional is reportedly negotiating for a stake in Acibadem, the Turkish hospital group 92%-owned by Almond Holding AS. Almond is a joint venture between Abraaj Capital and Turkey’s Aydinlar family.
Fortis ends bid for Turkish hospital owner Acibadem
Indian hospital operator Fortis Healthcare International has reportedly ended negotiations to purchase Acibadem, a Turkish hospital 92%-owned by Almond Holding AS. Almond is a joint venture between Abraaj Capital and Turkey’s Aydinlar family.
Franklin Templeton commits $9m to Indian pharma firm
Franklin Templeton Private Equity Strategy (FTPES) has invested INR450 million ($9.2 million) in Symbiotec Pharmalab, a company that produces active pharmaceutical ingredients. Details of the transaction were not disclosed.
Carlyle acquires healthcare staffing firm NIC for $149m
Carlyle has acquired Tokyo-based medical staffing services firm NIC Corp. for JPY11.5 billion ($149 million). The investment was made from its JPY165.6 billion yen-denominated Carlyle Japan Partners II fund, which targets mid-sized companies. It is the...
Archer, Ironbridge consider iNova Pharmaceuticals sale
Archer Capital and Ironbridge are looking to sell iNova Pharmaceuticals for A$700-850 million ($714-878 million). The private equity firms have appointed Greenhill Caliburn to advise on the sale process and would like to have a deal in place by the end...
Tokio Marine puts Japanese drug maker up for sale
Japanese buyout firm Tokio Marine Capital is reportedly set to exit its majority stake in Showa Yakuhin Kako, a domestic drug making company, and has hired Citigroup to advise on the sale.
Australian VC firms back Spinifex Pharmaceuticals
GBS Venture Partners, Brandon Capital Partners, Uniseed Management and UniQuest have participated in the Series B round of financing for Spinifex Pharmaceuticals. The Australian drug development company raised a total of $19 million, $6.5 million more...
Turnarounds in Thailand
Any discussion of private equity opportunities in Southeast Asia seems to hone in on Indonesia. Rich in commodities and with high household consumption levels, the country is perceived as large and lucrative enough for big ticket transactions. Thailand...
Matrix commits $9.9m to Kids Clinic India's Series A round
Matrix Partners India has committed INR450 million ($9.9 million) as the sole institutional investor in Kids Clinic India Private Limited, a Bangalore-based provider of maternity and infant care services. The immediate goal is to enlarge the company’s...
Former Infosys CFO to launch India PE fund
T.V. Mohandas Pai, the former CFO of Infosys, is reportedly planning to raise a private equity fund worth $100 million and is already closing in on his first investment.
MediAngels seeks $10m private equity investment
MediAngels, an India-based online medical consultation platform, is in talks with private equity funds over a $10 million investment, The Times of India reported. “We are in deep talks with four of the biggest US-based PE funds," said Dr. Debraj Shome,...
Audit concerns highlighted at two more Carlyle firms in China
Auditing procedures and financial controls have been called into question at China Energy Recycling and Concord Medical Services, both of which are in The Carlyle Group’s China portfolio, Reuters reported. This comes after fraud investigations at China...
Strategic Ventures sees 4x return on CBaySystems stake sale
Strategic Ventures Fund (SVF), a Mauritius-based private equity fund managed by Frontline Strategy Limited, has sold its stake in in Indian clinical-services outsourcing specialist CBaySystems, for a 4x return on its original investment, AltAssets reported....
CMIA's $200m fund to focus on China agribusiness, healthcare
CMIA Capital Partners has launched its fourth growth capital fund, worth $200 million, which will primarily seek out opportunities in China, notably in the agricultural sector.
VC firms, Mayo Clinic lead investment in Wuhan Kindstar
WI Harper Group, Baird Capital Partners, Morningside Ventures and the Mayo Clinic have committed $11 million in a Series B funding to Wuhan Kindstar Diagnostics, a clinical testing service provider in China.